All News

2061 articles, sorted by publication time.

Biotechnology · global

Filling the Experimental Data Gap for “Virtual Cells”: Biohub Expands $1.8 Billion Initiative with the U.S. Government and Tech Industry

For AI to predict how cells respond to drugs, researchers must first measure how life changes. This cross-sector collaboration will integrate new experiments, computing resources and existing data, but open sharing will follow different timelines, and its effectiveness in treating disease has yet to be validated.

Biotechnology R&D · global

Tracking RNA Therapy Effects Across More Than 10,000 Samples: PacBio and TychoBio Partner to Build AI Training Data

Once an antisense nucleic acid enters a cell, which RNAs does it change? The two companies plan to use full-length sequencing to connect drug design with cellular responses and build predictive tools for rare disease therapies; whether the models can accurately assess efficacy and unintended effects remains to be validated.

Drug Development · global

About 37 fewer minutes of uncontrolled symptoms each day: Parkinson’s drug solengepras meets Phase 3 trial endpoint

Cerevance announced that its oral GPR6 inhibitor can reduce daily OFF time in patients with Parkinson’s disease and improve some measures of daily activities. The therapy, which uses a new mechanism of action, met its Phase 3 primary endpoint, but full data are still needed to determine how long the benefits last and assess long-term safety.